PIERIS PHARMACEUTICALS, INC. - FORM 10-K - EX-32.1 - EXHIBIT 32.1 - March 13, 2020

Attached files

file filename
EX-32.2 - EXHIBIT 32.2 - PIERIS PHARMACEUTICALS, INC.pirs12-31x2019ex322.htm
EX-31.2 - EXHIBIT 31.2 - PIERIS PHARMACEUTICALS, INC.pirs12-31x2019ex312.htm
EX-31.1 - EXHIBIT 31.1 - PIERIS PHARMACEUTICALS, INC.pirs12-31x2019ex311.htm
EX-23.1 - EXHIBIT 23.1 - PIERIS PHARMACEUTICALS, INC.pirs12-31x2019ex231.htm
EX-21.1 - EXHIBIT 21.1 - PIERIS PHARMACEUTICALS, INC.pirs12-31x2019ex211.htm
EX-14.1 - EXHIBIT 14.1 - PIERIS PHARMACEUTICALS, INC.pirs12312019ex141.htm
EX-10.32 - EXHIBIT 10.32 - PIERIS PHARMACEUTICALS, INC.pirs12312019exh1032.htm
EX-10.31 - EXHIBIT 10.31 - PIERIS PHARMACEUTICALS, INC.pirs12312019exh1031.htm
EX-10.26 - EXHIBIT 10.26 - PIERIS PHARMACEUTICALS, INC.pirs12312019ex1026.htm
EX-10.25 - EXHIBIT 10.25 - PIERIS PHARMACEUTICALS, INC.pirs12312019ex1025.htm
EX-10.16 - EXHIBIT 10.16 - PIERIS PHARMACEUTICALS, INC.pirs12312019ex1016.htm
EX-4.3 - EXHIBIT 4.3 - PIERIS PHARMACEUTICALS, INC.pirs12312019ex-43.htm
10-K - 10-K - PIERIS PHARMACEUTICALS, INC.pirs12-31x201910xk.htm


Exhibit 32.1
CERTIFICATIONS UNDER SECTION 906
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), the undersigned officer of Pieris Pharmaceuticals, Inc., a Nevada corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:
The Annual Report for the year ended December 31, 2019 (the “Form 10-K”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
Dated: March 13, 2020
/s/ Stephen S. Yoder
 
Stephen S. Yoder
 
Title:
Chief Executive Officer and President
 
 
(principal executive officer)



PIERIS PHARMACEUTICALS, INC. Reports